Curetis delivers clear direction for rapid diagnosis of pneumonia in hospitalized patients. Unyvero is the only FDA-cleared molecular Pneumonia panel that detects Pneumocystis and a broad spectrum of clinically relevant bacterial pathogens and antibiotic resistance markers associated with pneumonia to inform rapid diagnosis and earlier appropriate antibiotic treatment decisions. FDA-cleared for BAL and endotracheal aspirate specimens. One patient sample, comprehensive results, Unyvero.
Countries of Interest: 1. All Countries listed below